Epic Research

Wednesday, December 27, 2017

Sensex, Nifty trade flat; Sun Pharma jumps 6%, RCom most active


Sun Pharma to acquire Ranbaxy in $4 billion all-stock deal
Benchmark indices continued to consolidate in afternoon after hitting life-time highs.
The 30-share BSE Sensex was up 36.33 points at 34,046.94 and the 50-share NSE Nifty rose 1.30 points to 10,532.80.
About 1,422 shares advanced against 1,094 declining shares on the BSE.
Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market its generic version of Fondaparinux Sodium injection used to prevent deep vein thrombosis.

For more information and best STOCK TIPS Call us ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Connect with our social media sites

No comments:

Post a Comment